Back to Search
TIMOTHY BOONE, MD
MD
Sports Medicine (Family Medicine) Physician
NPI: 1225425002IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Sports Medicine (Family Medicine) PhysicianPrimary
Family Medicine — Sports Medicine
Code: 207QS0010X
A165077(CA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Class of 2015
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
PMID 20156378·Can J Urol·2010
8-other
Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes.
PMID 20001469·Aging Male·2010
3-trial
Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
PMID 19220267·BJU Int·2009
8-other
Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
PMID 18510659·BJU Int·2008
4-observational
Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder.
PMID 18423678·J Urol·2008
8-other
Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial.
PMID 18990175·BJU Int·2008
3-trial
Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
PMID 17924444·Neurourol Urodyn·2008
8-other
A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder.
PMID 16530611·Eur Urol·2006
6-review
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.
PMID 17105794·JAMA·2006
4-observational
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder.
PMID 15476515·BJU Int·2004
4-observational
Fully human monoclonal antibodies antagonizing the glucagon receptor improve glucose homeostasis in mice and monkeys.
PMID 19129372·J Pharmacol Exp Ther·2009
7-preclinical
Urodynamic testing in evaluation of postradical prostatectomy incontinence before artificial urinary sphincter implantation.
PMID 19371935·Urology·2009
8-other
Light-induced aggregation of type I soluble tumor necrosis factor receptor.
PMID 19384921·J Pharm Sci·2009
8-other
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.
PMID 19049336·J Bone Miner Res·2009
7-preclinical
Comparative assessment of antimicrobial activities of antibiotic-treated penile prostheses.
PMID 19135292·Eur Urol·2009
4-observational
Construct validity of the pig intestine model in the simulation of laparoscopic urethrovesical anastomosis: tools for objective evaluation.
PMID 19099517·J Endourol·2008
7-preclinical
Activation of cholinergic receptors blocks non-adrenergic non-cholinergic contractions in the rat urinary bladder.
PMID 18755252·Brain Res Bull·2008
7-preclinical
Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.
PMID 18187233·Neurochem Int·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 8401 CONNECTICUT AVE PH SUITE
CHEVY CHASE, MD 20815 - Phone
- (202) 627-1904
Quick Facts
- NPI
- 1225425002
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 11
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile